18 Grants
2017
Vascular-targeted genomic and genetic strategies for acute chest syndrome
Machado, Roberto F
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL111656-05), $513,649USD, 02/05/2013 -- 01/31/2018
2016
Vascular-targeted genomic and genetic strategies for acute chest syndrome
Machado, Roberto F
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 4R01HL111656-04), $513,649USD, 02/05/2013 -- 01/31/2018
2015
Vascular-targeted genomic and genetic strategies for acute chest syndrome
Machado, Roberto F
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL111656-03), $521,655USD, 02/05/2013 -- 01/31/2016
2014
Carbon monoxide therapy for severe pulmonary arterial hypertension
Machado, Roberto F
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5K23HL098454-05), $131,382USD, 08/11/2010 -- 05/31/2015
 
Vascular-targeted genomic and genetic strategies for acute chest syndrome
Machado, Roberto F
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL111656-02), $519,007USD, 02/05/2013 -- 01/31/2018
2013
Carbon monoxide therapy for severe pulmonary arterial hypertension
Machado, Roberto F
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5K23HL098454-04), $131,382USD, 08/11/2010 -- 05/31/2015
 
Vascular-targeted genomic and genetic strategies for acute chest syndrome
Machado, Roberto F
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 1R01HL111656-01A1), $620,064USD, 02/05/2013 -- 01/31/2018
2012
Carbon monoxide therapy for severe pulmonary arterial hypertension
Machado, Roberto F
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5K23HL098454-03), $131,382USD, 08/11/2010 -- 05/31/2015
2011
Carbon monoxide therapy for severe pulmonary arterial hypertension
Machado, Roberto F
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5K23HL098454-02), $131,382USD, 08/11/2010 -- 05/31/2015
2010
Carbon monoxide therapy for severe pulmonary arterial hypertension
Machado, Roberto F
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 1K23HL098454-01A1), $131,382USD, 08/11/2010 -- 05/31/2015
2008
Cardiopulmonary Function Assessment and NO Based Therapies for SCD Pts with PAH
Machado, Roberto F
National Institutes of Health (NIH), Clinical Center (CLC) (ID: 1Z01CL008088-03), 2008
 
Effects of Inhaled Carbon Monoxide on Human Lung Inflammation
Machado, Roberto F
National Institutes of Health (NIH), Clinical Center (CLC) (ID: 1Z01CL008083-04), 2008
 
Evaluation of Endothelial Function in HIV Associated PAH
Machado, Roberto F
National Institutes of Health (NIH), Clinical Center (CLC) (ID: 1Z01CL008089-03), 2008
 
Treatment of PH and SCD with Sildenafil Therapy
Machado, Roberto
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 1Z01HL005116-02), $699,914USD, 2008
2007
Treatment of PH and SCD with Sildenafil Therapy
Machado, Roberto
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 1Z01HL005116-01), $534,977USD, 2007
2006
Cardiopulmonary Function Assessment and NO Based Therapi
Machado, Roberto F
National Institutes of Health (NIH), Clinical Center (CLC) (ID: 1Z01CL008088-01), 2006
 
Evaluation of Endothelial Function in HIV Associated PAH
Machado, Roberto F
National Institutes of Health (NIH), Clinical Center (CLC) (ID: 1Z01CL008089-01), 2006
2005
Effects of Carbon Monoxide on Human Lung Inflammation
Machado, Roberto F
National Institutes of Health (NIH), Clinical Center (CLC) (ID: 1Z01CL008083-01), 2005